Mitral valve surgery
Mitral valve surgery has been studied in 5 papers since 2021: 5 observational studies in people. The newest paper, Sep 22, 2025: “Trends and Late Outcomes in Elderly Patients Undergoing Mitral Valve Interventions in the United States”.
5 papers study it2 findingsUpdated
“MV intervention (HR 0.45, 95% CI 0.25 to 0.83, p = 0.011) and angiotensin converting enzyme inhibitor/angiotensin receptor blocker use (HR 0.39, 95% CI 0.20 to 0.79, p = 0.009) were associated with an improved prognosis”
None of its findings points the other way.
- 2 independent labs in 2 countries
- 1 of 2 findings with company ties
- Humans5
What did studies of Mitral valve surgery find?
1Studies of Mitral valve surgery measured 1 outcome; the most studied are secondary mitral regurgitation (1 study).
Secondary mitral regurgitation
downin humans1
1 study
Secondary mitral regurgitation
downin humans1
Mitral valve surgery is linked with lower secondary mitral regurgitation in humans (secondary mitral regurgitation with poor left ventricular ejection fraction <=30%) (p<0.001).
“Postoperative echocardiograms showed significantly improved mitral regurgitation, from moderate to severe to less than trivial (p<0.001)”
Humanssecondary mitral regurgitation with poor left ventricular ejection fraction <=30%58 malessn = 69
Results of mitral valve surgery for secondary regurgitation with poor left ventricular function
Preprint
What is Mitral valve surgery linked with?
1Studies link Mitral valve surgery with 1 measure, most often mortality (1 study).
Mortality
downin humans1HR 0.45
1 study
Mortality
downin humans1HR 0.45
Mitral valve surgery is linked with a lower risk of mortality in humans (severe mitral stenosis resulting from mitral annular calcification) (HR 0.45, 95% CI 0.25 to 0.83, p = 0.011).
“MV intervention (HR 0.45, 95% CI 0.25 to 0.83, p = 0.011) and angiotensin converting enzyme inhibitor/angiotensin receptor blocker use (HR 0.39, 95% CI 0.20 to 0.79, p = 0.009) were associated with an improved prognosis”
Humanssevere mitral stenosis resulting from mitral annular calcificationmedian follow-up of 360 daysn = 283
The American journal of cardiology